According to Burning Rock Biotech's latest financial reports the company has $87.01 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $0.13 B | -44.05% |
2021-12-31 | $0.23 B | -32.21% |
2020-12-31 | $0.34 B | 492.29% |
2019-12-31 | $58.43 M | 208.84% |
2018-12-31 | $18.92 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
LabCorp LH | $99.3 M | 14.11% | ๐บ๐ธ USA |
OpGen
OPGN | $0.29 M | -99.66% | ๐บ๐ธ USA |
NeoGenomics
NEO | $0.38 B | 342.24% | ๐บ๐ธ USA |